Cas:2905-30-8 4,4′-dimethylbiphenyl manufacturer & supplier

We serve Chemical Name:4,4′-dimethylbiphenyl CAS:2905-30-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4,4'-dimethylbiphenyl

Chemical Name:4,4′-dimethylbiphenyl
CAS.NO:2905-30-8
Synonyms:MFCD00008545;3,4-Dimethylbenzolsulfonylchlorid;(3,4-dimethylphenyl)chlorosulfone;3,4-xylene sulphonyl chloride;3,4-Dimethylbenzenesulphonyl chloride;3,4-Dimethyl-benzenesulfonyl chloride;3,4-Dimethylbenzene-1-sulfonyl chloride;EINECS 210-337-7;4,4′-DIMETHYLBIPHENYL
Molecular Formula:C8H9ClO2S
Molecular Weight:204.67400
HS Code:2904909090

Physical and Chemical Properties:
Melting point:118-120 °C(lit.)
Boiling point:295 °C(lit.)
Density:1.29 g/cm3
Index of Refraction:1.538
PSA:42.52000
Exact Mass:204.00100
LogP:3.31170

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3261
Packing Group:II


Contact us for information like MFCD00008545 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,4′-DIMETHYLBIPHENYL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,4′-DIMETHYLBIPHENYL Use and application,MFCD00008545 technical grade,usp/ep/jp grade.


Related News: Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY. 1,1,2,2-Tetramethyl-hexylamin manufacturers MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world. 4-(methoxy-d3)-2,6-dimethyl-1,2,3,4-tetrahydroquinoline suppliers CDMOs closely work with companies who want to pursue upcoming innovations in medicines, help cope with shortcomings of internal lab-to-manufacturing scale-up. N-(3-hexadecanamidooctadecanoyl)-β-alanyl-L-phenylalanine benzyl ester vendor & factory Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY.,While Stevanato has been in the headlines for its involvement in the fight against Covid-19—its factories immediately sprang to work producing vials and syringes for vaccines when Italy was still under lockdown in April 2020—vaccines only made up 4% of the company’s revenues in 2020 and 2019.